Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Purpura, Thrombocytopenic, Autoimmune”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT02877706
What this trial is testing

French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia

Who this might be right for
Immune ThrombocytopeniaAutoimmune Hemolytic Anemia
University Hospital, Toulouse 1,500
Large-scale testing (Phase 3)Study completedNCT00168038
What this trial is testing

Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10

Who this might be right for
Immune Thrombocytopenic Purpura
CSL Behring 58
Large-scale testing (Phase 3)Study completedNCT05621330
What this trial is testing

Efficacy and Safety of QL0911 in Adult Patients With Chronic Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
Qilu Pharmaceutical Co., Ltd. 216
Not applicableLooking for participantsNCT07786077
What this trial is testing

Patients' Preferences for Primary Immune Thrombocytopenia Treatment

Who this might be right for
Primary Immune Thrombocytopenia
Novartis Pharmaceuticals 100
Not applicableStudy completedNCT03154385
What this trial is testing

Efficacy and Safety Assessment of a Treatment Combining Rituximab and Belimumab in Adults With Persistent Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Assistance Publique - Hôpitaux de Paris 15
Testing effectiveness (Phase 2)UnknownNCT06686927
What this trial is testing

Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITP

Who this might be right for
Primary Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 36
Testing effectiveness (Phase 2)Looking for participantsNCT07043946
What this trial is testing

A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia (ITP)ITPBiologics+2 more
Climb Bio, Inc. 24
Testing effectiveness (Phase 2)UnknownNCT05932524
What this trial is testing

Low-dose Baricitinib Plus High-dose Dexamethasone for Patients With Newly Diagnosed Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 132
Post-approval studies (Phase 4)Study completedNCT03229746
What this trial is testing

Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Assiut University 40
Testing effectiveness (Phase 2)WithdrawnNCT05509582
What this trial is testing

Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated Cytopenias

Who this might be right for
Immune Mediated AnemiaImmune Mediated ThrombocytopeniaChronic GVHD
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableStudy completedNCT01727232
What this trial is testing

Efficacy and Safety of Rituximab Given at Fixed Dose (1000 mg on Days 1 and 15) Compared to the Standard Regimen in Adult's Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
Henri Mondor University Hospital 107
Large-scale testing (Phase 3)Study completedNCT00102323
What this trial is testing

AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy

Who this might be right for
ThrombocytopeniaIdiopathic Thrombocytopenic Purpura
Amgen 63
Testing effectiveness (Phase 2)Study completedNCT04346654
What this trial is testing

Assess Efficacy and Safety of Eltrombopag in Combination With a Short Course of Dexamethasone in Patients With Newly Diagnosed ITP

Who this might be right for
Immune Thrombocytopenia (ITP)
Novartis Pharmaceuticals 26
Testing effectiveness (Phase 2)Looking for participantsNCT06776510
What this trial is testing

A Clinical Study of NAD in the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 20
Not applicableUnknownNCT02967328
What this trial is testing

RP% Measurement by FCM as a Diagnostic Test for ITP

Who this might be right for
Immune Thrombocytopenia
Shandong University 500
Post-approval studies (Phase 4)Ended earlyNCT03866798
What this trial is testing

Study to Evaluate the Efficacy and Safety of PANZYGA in Pediatric Patients With Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Chronic Immune Thrombocytopenia
Octapharma 6
Testing effectiveness (Phase 2)Study completedNCT00860600
What this trial is testing

Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients

Who this might be right for
Idiopathic Thrombocytopenic Purpura (ITP)
PhytoHealth Corporation 14
Testing effectiveness (Phase 2)UnknownNCT05494307
What this trial is testing

The Combination of Terbutaline and Danazol as the Treatment of Corticosteroid-resistant/Relapse Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 228
Testing effectiveness (Phase 2)UnknownNCT06577909
What this trial is testing

Prednisone Plus IVIg vs. Prednisone for ITP During Pregnancy

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 100
Early research (Phase 1)Ended earlyNCT00244257
What this trial is testing

Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Genzyme, a Sanofi Company 10
Next Page